Background: Suicide poses a significant health burden worldwide. In many cases, people at risk of suicide do not engage with their doctor or community due to concerns about stigmatisation and forced medical treatment; worse still, people with mental illness (who form a majority of people who die from suicide) may have poor insight into their mental state, and not self-identify as being at risk. These issues are exacerbated by the fact that doctors have difficulty in identifying those at risk of suicide when they do present to medical services. Advances in artificial intelligence (AI) present opportunities for the development of novel tools for predicting suicide.Method: We searched Google Scholar and PubMed for articles relating to suicide prediction using artificial intelligence from 2017 onwards.Conclusions: This paper presents a qualitative narrative review of research focusing on two categories of suicide prediction tools: medical suicide prediction and social suicide prediction. Initial evidence is promising: AI-driven suicide prediction could improve our capacity to identify those at risk of suicide, and, potentially, save lives. Medical suicide prediction may be relatively uncontroversial when it pays respect to ethical and legal principles; however, further research is required to determine the validity of these tools in different contexts. Social suicide prediction offers an exciting opportunity to help identify suicide risk among those who do not engage with traditional health services. Yet, efforts by private companies such as Facebook to use online data for suicide prediction should be the subject of independent review and oversight to confirm safety, effectiveness and ethical permissibility.

Methadone maintenance therapy is a cost-effective, evidence-based treatment for heroin dependence. In the USA, a majority of heroin-dependent offenders are forced to detox from methadone when incarcerated. Recent research published in The Lancet has demonstrated the negative health and economic outcomes associated with such policies (Rich, J. D., McKenzie, M., Larney, S., Wong, J. B., Tran, L., Clarke, J. et al. (2015). Methadone Continuation Versus Forced Withdrawal on Incarceration in a Combined US Prison and Jail: A Randomised, Open Label Trial. The Lancet, 386, 350–359). This novel evidence raises questions as to the justification for current policies of forced detox in American prisons. Opponents of methadone provision in prisons might offer arguments from retributivism, resource allocation and curative effectiveness to justify their position. This article contends that these arguments do not stand up to ethical scrutiny. In light of this, we hold that American policymakers should reform criminal justice policies to allow the initiation and continuation of methadone treatment in correctional settings. This would be consistent with both international recommendations and the example set by a number of other Western countries.